Novolin 70/30 and Eye disorder - a phase IV clinical study of FDA data

Summary:

Eye disorder is reported as a side effect among people who take Novolin 70/30 (insulin recombinant purified human; insulin susp isophane semisynthetic purified human), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Blood pressure abnormal.

The phase IV clinical study analyzes which people have Eye disorder when taking Novolin 70/30. It is created by eHealthMe based on reports of 1,581 people who have side effects when taking Novolin 70/30 from the FDA, and is updated regularly.

What is Novolin 70/30?

Novolin 70/30 has active ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human. It is often used in diabetes. eHealthMe is studying from 1,611 Novolin 70/30 users. Check the latest studies of Novolin 70/30.

What is Eye disorder?

Eye disorder is found to be associated with 1,353 drugs and 1,452 conditions by eHealthMe. Check the latest studies of Eye disorder.

On Jul, 11, 2026

1,581 people reported to have side effects when taking Novolin 70/30.
Among them, 15 people (0.95%) have Eye disorder.

Among these 15 people:

How long have people been on Novolin 70/30 when they have Eye disorder? *

What is the gender of people who have Eye disorder when taking Novolin 70/30? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Eye disorder when taking Novolin 70/30? *

What are other drugs people take besides Novolin 70/30? *

What are other side effects people have besides Eye disorder? *

Blood Glucose Increased: 3 people, 20.00%
Visual Impairment: 3 people, 20.00%
Renal Disorder (kidney disease): 3 people, 20.00%
Pain: 3 people, 20.00%
Injury: 2 people, 13.33%
Joint Pain: 2 people, 13.33%
Cough: 2 people, 13.33%
Confusional State: 2 people, 13.33%
Pulmonary Oedema (fluid accumulation in the lungs): 2 people, 13.33%
Diabetes Mellitus Inadequate Control: 2 people, 13.33%

What are the existing conditions these people have? *

Type 2 Diabetes: 2 people, 13.33%
High Blood Cholesterol: 2 people, 13.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 13.33%
Blood Pressure Abnormal: 2 people, 13.33%
Thyroid Diseases: 1 person, 6.67%
Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 1 person, 6.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.67%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 1 person, 6.67%
Hypersensitivity: 1 person, 6.67%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Novolin 70/30 and have Eye disorder?

- Check whether Eye disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolin 70/30:

Novolin 70/30 (1,611 reports)

Eye disorder treatments and more:

Eye disorder (40,666 reports)

How severe was Eye disorder and when was it recovered:

Eye disorder in Novolin 70/30

Expand to all the drugs that have ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human:

Eye disorder and drugs with ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novolin 70/30:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye disorder:

Eye disorder (1,353 drugs)

Browse all the conditions that are associated with Eye disorder:

Eye disorder (1,452 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant purified human; insulin susp isophane semisynthetic purified human (the active ingredients of Novolin 70/30) and Novolin 70/30 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.